Dopamine receptor agonists differ in their actions on cardiac ion channels.

Hurst, Raymond S; Higdon, Nicole R; Lawson, Judy A; Clark, Michael A; Rutherford-Root, Karen L; McDonald, William G; Haas, Joseph V; McGrath, James P; Meglasson, Martin D

Hurst, Raymond S; Higdon, Nicole R; Lawson, Judy A; Clark, Michael A; Rutherford-Root, Karen L; McDonald, William G; Haas, Joseph V; McGrath, James P; Meglasson, Martin D.

Affiliation

Hurst RS; Department of Pharmacology, Pharmacia Corporation, Kalamazoo, MI 49007, USA. raymond.s.hurst@pfizer.com

Eur J Pharmacol ; 482(1-3): 31-7, 2003 Dec 15.

Article in En | MEDLINE | ID: mdl-14660002

Subject(s)

Cation Transport Proteins/antagonists & inhibitors; Cation Transport Proteins/metabolism; Dopamine Agonists/pharmacology; Potassium Channels, Voltage-Gated; Potassium Channels/metabolism; Purkinje Fibers/drug effects; Purkinje Fibers/metabolism; Receptors, Dopamine/physiology; Action Potentials/drug effects; Action Potentials/physiology; Animals; CHO Cells; Cricetinae; Dogs; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; In Vitro Techniques; Male; Potassium Channel Blockers/pharmacology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Purkinje Fibers / Potassium Channels / Receptors, Dopamine / Dopamine Agonists / Potassium Channels, Voltage-Gated / Cation Transport Proteins Limits: Animals Language: En Year: 2003 Type: Article

Search on Google

XML

PubMed Links